Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Preotact plus calcium/vitamin D versus calcium/vitamin D in postmenopausal osteoporosis: effects on glucose tolerance and energy metabolism
2009-012397-12Phase 4Active
- Sponsor
- AOU Città della Salute e della Scienza di Torino
- Start
- Jul 2009
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, open-label trial of parathyroid hormone 1-84 in postmenopausal osteoporosis (2 arms), sponsored by AOU Città della Salute e della Scienza di Torino. Primary endpoints: Effect of intermittent PTH 1-84 on glucose tolerance and energy expenditure, Glucose tolerance by oral glucose tolerance test and 2 more. Started Jul 2009; status: active.
02
Drugs
parathyroid hormone 1-84
03
Conditions
postmenopausal osteoporosis
Beyond the preview
Go deeper on 2009-012397-12.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-012397-12.